Exercise without foot pressure: a new path for diabetic ulcer patients?

NCT ID NCT06092827

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 04, 2026 · Last updated Sep 04, 2026

Summary

This trial tests a 12-week exercise program designed for people with diabetic foot ulcers who must avoid putting weight on their feet. Participants do aerobic, resistance, and flexibility exercises while wearing an offloading device, with two supervised sessions and one home session per week. Researchers measure whether the program is feasible and acceptable, and also track fitness levels and daily step counts. The goal is to see if this approach can help people stay physically active without harming their healing feet.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
A 12-week non-weight-bearing physical activity program combining aerobic, resistance, and flexibility exercises, with two supervised sessions and one home-based session per week.
What this could lead to
If this program proves feasible and acceptable, it could offer a safe way for people with diabetic foot ulcers to stay physically active, potentially improving heart and lung fitness and daily step counts without delaying wound healing.
What could go wrong
This is a small feasibility study with only 12 participants, so results may not apply broadly. The program requires commitment to both exercise and wound care, and some people may find it hard to stick with or may not see clear fitness gains.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

12 people

The number who actually took part.

Started

Dec 2023

Finished

Jul 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 75 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

For individuals with a diabetic foot ulcer: Inclusion: * Male or female * Aged over 18 up to 75 years * Willing to engage in PA (physical activity) * Committed to following wound care recommendations to the best of their ability for the duration of the study * Understand and read French. Exclusion: * Uncontrolled DFU infection * Use of a non-removable offloading modality (total contact cast) * Uncontrolled hyperglycemia (HbA1c ≥ 10.0% or fasting blood glucose ≥ 16.0 mmol/L for ≥ 2 consecutive days) confirmed by blood sample results during the initial assessment or access to recent blood test results (within the last 3 months) or the log of home capillary blood glucose readings * Participation in sports or regular intense physical activities (≥ 2 times per week) * The following pre-existing heart problems: a cardiovascular event (myocardial infarction, heart surgery, etc.) in the last 3 months, unstable cardiovascular disease (uncontrolled hypertension, i.e., ≥ 160/90 mmHg, uncompensated heart failure, etc.), chest pain and exertional dyspnea and/or uninvestigated intermittent claudication * Recent neurovascular problem (stroke, transient ischemic attack, etc.) in the last 3 months * Health problem that the research team considers a contraindication to participating in the study * Diabetes complication making moderate-intensity PA unsafe, such as untreated proliferative diabetic retinopathy or a sensitivity disorder to hypoglycemia, critical ischemia of one or both lower limbs. For kinesiologists: Inclusion: * Have completed a bachelor's degree in kinesiology * Understand, read, and speak French. Exclusion: None

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cardiopulmonary are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Diabetic Foot Sedentary Behavior

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Universite du Quebec à Trois-Rivieres

    Trois-Rivières, Quebec, G8Z 4M3, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.